Enquiry/Quote
Cisatracurium Besylate bulk supplier for pharma manufacturers

Cisatracurium Besylate Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/ml

Reference Brands: Nimbex (USA/EU)

Category: Anaesthetics

Cisatracurium besylate is a nondepolarizing skeletal neuromuscular blocker for intravenous administration. Compared to other neuromuscular blockers, it is intermediate in its onset and duration of action. Cisatracurium Besylate is available in Injection and strengths such as 2 mg/ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cisatracurium Besylate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Cisatracurium Besylate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Cisatracurium besilate undergoes Hofmann elimination which makes this as a drug of choice in organ failure patients. Keywords:Cisatracurium, Neuromuscular blocking agent, Nondepolarizing. Introduction blockers are available General anesthesia (GA) is commonly practiced due to various disadvantages seen with regional techniques.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Cisatracurium besylate is used as a neuromuscular blocking agent to facilitate tracheal intubation and provide skeletal muscle relaxation during surgical procedures or in intensive care settings for mechanically ventilated patients.

Cisatracurium besylate is a synthetic benzylisoquinolinium compound formulated as the besylate (benzene sulfonate) salt. It is manufactured through controlled pharmaceutical chemical synthesis.

The primary trade name is Nimbex in the USA, UK, and EU, along with generic versions.

Nimbex has been marketed by pharmaceutical companies such as GlaxoSmithKline and later by other licensed manufacturers depending on the region. Generic versions are produced by multiple manufacturers worldwide.

The generic name is cisatracurium besylate.

The main brand name is Nimbex.

Cisatracurium besylate injection is manufactured by various pharmaceutical companies in the USA, UK, EU, India, and other countries, depending on the brand or generic manufacturer.

Yes, Cisatracurium Besylate is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Cisatracurium Besylate is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Sufentanil Citrate

Strength:
50 mcg/mL, 100 mcg/mL, 15 mcg

Form: Tablet / Injection

Reference Brands: Sufenta (USA/EU), Dsuvia (USA/EU)

View Details
Pancuronium Bromide

Strength:
1 mg/mL, 2 mg/mL

Form: Injection

Reference Brands: Pavulon (USA/EU)

View Details
Dyclonine Hydrochloride

Strength:
0.5% w/v, 1% w/v

Form: topical solution/ lozenges / sprays

Reference Brands: Sucrets Complete (USA)

View Details
Droperidol

Strength:
2.5 mg/mL , 5 mg/mL

Form: Injection

Reference Brands: Droleptan (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.